posted on March 13, 2013 14:54
Press Release for Pet Industry
A recent medical breakthrough in human health has been developed for the pet industry. LifeVantage, a publicly traded company, has released a canine form of its powerful Nrf2 Activator, Protandim. The Nrf2 antioxidant response pathway is “the primary cellular defense against the cytotoxic effects of oxidative stress.” Protandim is clinically proven to reduce oxidative stress in humans by 40% in the first 30 days. Dogs have greater levels of oxidative stress than humans and LifeVantage’s new product Canine Health is proving to be as effective on dogs as it is on humans. There is not another Nrf2 Activator available in the pet industry and nothing will have the powerful reduction of oxidative stress on dogs that Canine Health has for quite some time. Protandim has 5 United States Patents and a patent has been applied for on the Canine Health. Read the HTML information below to confirm the efficacy of Nrf2 Activation and be one of the first in your industry to be able to offer this powerful supplement to your patients.
Dr David S. Dyer
Independent LifeVantage Distributor